Cui C, Liu L, Qi Y, Han N, Xu H, Wang Z
Cardiovasc Diabetol. 2024; 23(1):156.
PMID: 38715129
PMC: 11077847.
DOI: 10.1186/s12933-024-02244-9.
Jeong Y, Lee K, Kim H, Kim Y
Nutr Res Pract. 2023; 17(6):1225-1237.
PMID: 38053820
PMC: 10694427.
DOI: 10.4162/nrp.2023.17.6.1225.
Wang Y, Fietze I, Salanitro M, Penzel T
Sleep Breath. 2022; 27(4):1315-1323.
PMID: 36269514
PMC: 10427704.
DOI: 10.1007/s11325-022-02727-7.
Wang B, Mo X, Wu Z, Guan X
J Thorac Dis. 2022; 14(3):646-653.
PMID: 35399239
PMC: 8987819.
DOI: 10.21037/jtd-22-78.
Zhang X, Yuan S, Wan G, Yuan M, Yang G, Fu H
Sci Rep. 2021; 11(1):4839.
PMID: 33649485
PMC: 7921127.
DOI: 10.1038/s41598-021-84015-0.
Culprit Lesion Characteristics in Young Patients with Hyperhomocysteinemia.
Hou F, Zhou Y, Ma X, He T, Yan R, Geng Q
Med Sci Monit. 2019; 25:5306-5311.
PMID: 31313754
PMC: 6659466.
DOI: 10.12659/MSM.914979.
Hyperhomocysteinemia Predicts the Severity of Coronary Artery Disease as Determined by the SYNTAX Score in Patients with Acute Coronary Syndrome.
Karadeniz M, Sarak T, Duran M, Alp C, Kandemir H, Celik I
Acta Cardiol Sin. 2018; 34(6):458-463.
PMID: 30449985
PMC: 6236564.
DOI: 10.6515/ACS.201811_34(6).20180528B.
Meta-Analysis of the Effects of Foods and Derived Products Containing Ellagitannins and Anthocyanins on Cardiometabolic Biomarkers: Analysis of Factors Influencing Variability of the Individual Responses.
Garcia-Conesa M, Chambers K, Combet E, Pinto P, Garcia-Aloy M, Andres-Lacueva C
Int J Mol Sci. 2018; 19(3).
PMID: 29495642
PMC: 5877555.
DOI: 10.3390/ijms19030694.
Design and rationale of the Cardiovascular Health and Text Messaging (CHAT) Study and the CHAT-Diabetes Mellitus (CHAT-DM) Study: two randomised controlled trials of text messaging to improve secondary prevention for coronary heart disease and....
Huo X, Spatz E, Ding Q, Horak P, Zheng X, Masters C
BMJ Open. 2017; 7(12):e018302.
PMID: 29273661
PMC: 5778311.
DOI: 10.1136/bmjopen-2017-018302.
The Role of Text Messaging in Cardiovascular Risk Factor Optimization.
Klimis H, Khan M, Kok C, Chow C
Curr Cardiol Rep. 2017; 19(1):4.
PMID: 28102482
DOI: 10.1007/s11886-017-0811-8.
Factors Influencing Engagement, Perceived Usefulness and Behavioral Mechanisms Associated with a Text Message Support Program.
Redfern J, Santo K, Coorey G, Thakkar J, Hackett M, Thiagalingam A
PLoS One. 2016; 11(10):e0163929.
PMID: 27741244
PMC: 5065147.
DOI: 10.1371/journal.pone.0163929.
A literature review of the cardiovascular risk-assessment tools: applicability among Asian population.
Liau S, Mohamed Izham M, Hassali M, Shafie A
Heart Asia. 2016; 2(1):15-8.
PMID: 27325935
PMC: 4898587.
DOI: 10.1136/ha.2009.001115.
Insulin-like growth factors and their potential role in cardiac epigenetics.
Iosef Husted C, Valencik M
J Cell Mol Med. 2016; 20(8):1589-602.
PMID: 27061217
PMC: 4956935.
DOI: 10.1111/jcmm.12845.
How do high glycemic load diets influence coronary heart disease?.
Mathews M, Liebenberg L, Mathews E
Nutr Metab (Lond). 2015; 12:6.
PMID: 25774201
PMC: 4359552.
DOI: 10.1186/s12986-015-0001-x.
Correlation of serum homocysteine levels with the severity of coronary artery disease.
Shenoy V, Mehendale V, Prabhu K, Shetty R, Rao P
Indian J Clin Biochem. 2014; 29(3):339-44.
PMID: 24966483
PMC: 4062675.
DOI: 10.1007/s12291-013-0373-5.
Investigation on cardiovascular risk prediction using physiological parameters.
Lin W, Zhang H, Zhang Y
Comput Math Methods Med. 2014; 2013:272691.
PMID: 24489599
PMC: 3893863.
DOI: 10.1155/2013/272691.
Hyperhomocysteinemia is an independent risk factor in young patients with coronary artery disease in southern China.
Wu Y, Huang Y, Hu Y, Zhong J, He Z, Li W
Herz. 2013; 38(7):779-84.
PMID: 23430091
DOI: 10.1007/s00059-013-3761-y.
Association between serum homocysteine concentration with coronary artery disease in Iranian patients.
Mirdamadi A, Farzamnia H, Varzandeh P, Almasi N, Arasteh M
ARYA Atheroscler. 2012; 7(2):63-7.
PMID: 22577448
PMC: 3347846.
Design and rationale of the tobacco, exercise and diet messages (TEXT ME) trial of a text message-based intervention for ongoing prevention of cardiovascular disease in people with coronary disease: a randomised controlled trial protocol.
Chow C, Redfern J, Thiagalingam A, Jan S, Whittaker R, Hackett M
BMJ Open. 2012; 2(1):e000606.
PMID: 22267690
PMC: 3263439.
DOI: 10.1136/bmjopen-2011-000606.
Periodontal disease as a risk marker in coronary heart disease and chronic kidney disease.
Fisher M, Borgnakke W, Taylor G
Curr Opin Nephrol Hypertens. 2010; 19(6):519-26.
PMID: 20948377
PMC: 3084591.
DOI: 10.1097/MNH.0b013e32833eda38.